Company intelligence / Profile preview
Chengdu Suncadia Pharmaceuticals
Chengdu, Sichuan, Chinahrssd.com.cn ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Chengdu Suncadia Pharmaceuticals is a subsidiary of Jiangsu Hengrui Medicine, focused on development and manufacturing of innovative small-molecule drugs and high-quality generic pharmaceuticals. Its products include anesthetics such as etomidate and a range of drugs for oncology and perioperative care; products are marketed in China, with rapid financial growth and more than 100 patents issued.[1][3][5]
- Therapeutic areas
- OtherOncology
- Modalities
- Small moleculeGeneric drug
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Chengdu Suncadia Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chengdu Suncadia Pharmaceuticals.